Akero Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025

Published: 2025-05-12 07:00:00 ET AKRO

Published on 05/12/2025 at 07:00, updated on 05/12/2025 at 08:36

Akero Therapeutics, Inc. reported earnings results for the first quarter ended March 31, 2025. For the first quarter, the company reported net loss was USD 70.73 million compared to USD 53.34 million a year ago. Basic loss per share from continuing operations was USD 0.9 compared to USD 0.9 a year ago.

Diluted loss per share from continuing operations was USD 0.9 compared to USD 0.9 a year ago.